 SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced its participation at this upcoming investor conference: 